(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||
The Nasdaq Capital Market | ||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). |
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Item 2.02. | Results of Operations and Financial Condition. |
Item 9.01 | Financial Statements and Exhibits. |
(d) | Exhibits. |
Exhibit No. | Description | ||||
CONFORMIS, INC. | ||||||||||||||||||||
Date: March 1, 2023 | By: | /s/ Robert S. Howe | ||||||||||||||||||
Robert S. Howe | ||||||||||||||||||||
Chief Financial Officer |
Three Months Ended December 31, | Increase/(decrease) | ||||||||||||||||||||||||||||||||||||||||
($, in thousands) | 2022 | 2021 | $ Change | % Change | % Change | ||||||||||||||||||||||||||||||||||||
(as reported) | (constant currency) | ||||||||||||||||||||||||||||||||||||||||
United States | $ | 12,360 | $ | 13,556 | $ | (1,196) | (9) | % | (9) | % | |||||||||||||||||||||||||||||||
Rest of world | 1,797 | 1,722 | 75 | 4 | % | 19 | % | ||||||||||||||||||||||||||||||||||
Product revenue | 14,157 | 15,278 | (1,121) | (7) | % | (6) | % | ||||||||||||||||||||||||||||||||||
Royalty and licensing revenue | 3,263 | 146 | 3,117 | 2,135 | % | 2,135 | % | ||||||||||||||||||||||||||||||||||
Total revenue | $ | 17,420 | $ | 15,424 | $ | 1,996 | 13 | % | 14 | % |
Twelve Months Ended December 31, | Increase/(decrease) | ||||||||||||||||||||||||||||||||||||||||
($, in thousands) | 2022 | 2021 | $ Change | % Change | % Change | ||||||||||||||||||||||||||||||||||||
(as reported) | (constant currency) | ||||||||||||||||||||||||||||||||||||||||
United States | $ | 50,527 | $ | 50,990 | $ | (463) | (1) | % | (1) | % | |||||||||||||||||||||||||||||||
Rest of world | 7,298 | 7,328 | (30) | — | % | 10 | % | ||||||||||||||||||||||||||||||||||
Product revenue | 57,825 | 58,318 | (493) | (1) | % | — | % | ||||||||||||||||||||||||||||||||||
Royalty and licensing revenue | 4,225 | 41,542 | (37,317) | (90) | % | (90) | % | ||||||||||||||||||||||||||||||||||
Total revenue | $ | 62,050 | $ | 99,860 | $ | (37,810) | (38) | % | (37) | % |
CONFORMIS, INC. AND SUBSIDIARIES | |||||||||||||||||||||||||||||||||||||||||
Consolidated Statements of Operations | |||||||||||||||||||||||||||||||||||||||||
(in thousands, except share and per share data) | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||||||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||||||||||||||
(unaudited) | (unaudited) | ||||||||||||||||||||||||||||||||||||||||
Revenue | |||||||||||||||||||||||||||||||||||||||||
Product | $ | 14,157 | $ | 15,278 | $ | 57,825 | $ | 58,318 | |||||||||||||||||||||||||||||||||
Royalty and licensing | 3,263 | 146 | 4,225 | 41,542 | |||||||||||||||||||||||||||||||||||||
Total revenue | 17,420 | 15,424 | 62,050 | 99,860 | |||||||||||||||||||||||||||||||||||||
Cost of revenue | 10,265 | 9,476 | 38,837 | 34,179 | |||||||||||||||||||||||||||||||||||||
Gross profit | 7,155 | 5,948 | 23,213 | 65,681 | |||||||||||||||||||||||||||||||||||||
Operating expenses | |||||||||||||||||||||||||||||||||||||||||
Sales and marketing | 6,519 | 7,053 | 25,308 | 24,904 | |||||||||||||||||||||||||||||||||||||
Research and development | 3,227 | 4,053 | 15,340 | 14,791 | |||||||||||||||||||||||||||||||||||||
General and administrative | 4,209 | 8,232 | 28,843 | 28,994 | |||||||||||||||||||||||||||||||||||||
Total operating expenses | 13,955 | 19,338 | 69,491 | 68,689 | |||||||||||||||||||||||||||||||||||||
Loss from operations | (6,800) | (13,390) | (46,278) | (3,008) | |||||||||||||||||||||||||||||||||||||
Other income and expenses | |||||||||||||||||||||||||||||||||||||||||
Interest income | 10 | 20 | 53 | 97 | |||||||||||||||||||||||||||||||||||||
Interest expense | (589) | (1,694) | (2,019) | (3,496) | |||||||||||||||||||||||||||||||||||||
Foreign currency exchange transaction income (loss) | 3,679 | (865) | (2,252) | (3,167) | |||||||||||||||||||||||||||||||||||||
Other income | — | — | — | 7,252 | |||||||||||||||||||||||||||||||||||||
Total other income (expenses) | 3,100 | (2,539) | (4,218) | 686 | |||||||||||||||||||||||||||||||||||||
Loss before income taxes | (3,700) | (15,929) | (50,496) | (2,322) | |||||||||||||||||||||||||||||||||||||
Income tax provision (benefit) | 16 | 47 | (23) | 91 | |||||||||||||||||||||||||||||||||||||
Net loss | $ | (3,716) | $ | (15,976) | $ | (50,473) | $ | (2,413) | |||||||||||||||||||||||||||||||||
Net loss per share | |||||||||||||||||||||||||||||||||||||||||
Basic and diluted* | $ | (0.51) | $ | (2.23) | $ | (6.99) | $ | (0.36) | |||||||||||||||||||||||||||||||||
Weighted average common shares outstanding | |||||||||||||||||||||||||||||||||||||||||
Basic and diluted* | 7,249,372 | 7,151,248 | 7,219,368 | 6,668,530 |
CONFORMIS, INC. AND SUBSIDIARIES | |||||||||||||||||||||||
Consolidated Balance Sheets | |||||||||||||||||||||||
(in thousands, except share and per share data) | |||||||||||||||||||||||
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||
Assets | (unaudited) | ||||||||||||||||||||||
Current Assets | |||||||||||||||||||||||
Cash and cash equivalents | $ | 48,667 | $ | 100,556 | |||||||||||||||||||
Accounts receivable, net | 9,773 | 9,079 | |||||||||||||||||||||
Royalty and licensing receivable | 134 | 280 | |||||||||||||||||||||
Inventories | 18,910 | 15,204 | |||||||||||||||||||||
Prepaid expenses and other current assets | 1,785 | 1,764 | |||||||||||||||||||||
Total current assets | 79,269 | 126,883 | |||||||||||||||||||||
Property and equipment, net | 8,154 | 10,268 | |||||||||||||||||||||
Operating lease right-of-use assets | 6,078 | 7,536 | |||||||||||||||||||||
Other Assets | |||||||||||||||||||||||
Restricted cash | 462 | 562 | |||||||||||||||||||||
Other long-term assets | 85 | 92 | |||||||||||||||||||||
Total assets | $ | 94,048 | $ | 145,341 | |||||||||||||||||||
Liabilities and stockholder's equity | |||||||||||||||||||||||
Current liabilities | |||||||||||||||||||||||
Accounts payable | $ | 4,163 | $ | 6,557 | |||||||||||||||||||
Accrued expenses | 7,978 | 9,576 | |||||||||||||||||||||
Operating lease liabilities | 1,932 | 1,830 | |||||||||||||||||||||
Total current liabilities | 14,073 | 17,963 | |||||||||||||||||||||
Other long-term liabilities | 230 | — | |||||||||||||||||||||
Long-term debt, less debt issuance costs | 20,563 | 20,355 | |||||||||||||||||||||
Operating lease liabilities | 5,003 | 6,471 | |||||||||||||||||||||
Total liabilities | 39,869 | 44,789 | |||||||||||||||||||||
Commitments and contingencies | |||||||||||||||||||||||
Stockholders' equity | |||||||||||||||||||||||
Preferred stock, $0.00001 par value: | |||||||||||||||||||||||
Authorized: 5,000,000 shares authorized at December 31, 2022 and December 31, 2021; no shares issued and outstanding as of December 31, 2022 and December 31, 2021 | — | — | |||||||||||||||||||||
Common stock, $0.00001 par value: | |||||||||||||||||||||||
Authorized: 20,000,000 shares authorized at December 31, 2022 and December 31, 2021; 7,502,462 and 7,441,668 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively* | — | 2 | |||||||||||||||||||||
Additional paid-in capital* | 634,647 | 632,513 | |||||||||||||||||||||
Accumulated deficit | (581,324) | (530,851) | |||||||||||||||||||||
Accumulated other comprehensive income (loss) | 856 | (1,112) | |||||||||||||||||||||
Total stockholders' equity | 54,179 | 100,552 | |||||||||||||||||||||
Total liabilities and stockholders' equity | $ | 94,048 | $ | 145,341 |
Cover |
Mar. 01, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Mar. 01, 2023 |
Entity Registrant Name | Conformis, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-37474 |
Entity Tax Identification Number | 56-2463152 |
Entity Address, Address Line One | 600 Technology Park Drive |
Entity Address, City or Town | Billerica |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 01821 |
City Area Code | 781 |
Local Phone Number | 345-9001 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.00001 par value per share |
Trading Symbol | CFMS |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001305773 |
Amendment Flag | false |
VK%U*6S88^S M)HC>>1)#[^5H98Z/6!+ MJXW#EGI,Y46O@6"BF'VDW*IAOC'/&"X#T/AP2SVIRCU$IEVIDA7USNLGK40' MP&-U "RW_C-E_75>\GRAJC 0K_%Z6@W]Z?W\%I@C[^L7.'TLG,W:&J44$5 T M/,G[8K%N);#(PDSETL=4)J\Y,2T\UJ4].G JM>S.DZU\-,["Y/D?6]>GI301QB22/,R_)E_4#7 M: <^]P-7]'YN"2\Z"CYK1T'+GO$7BL-9UTRXJ[Y>H.-&"+LZVY ;&_:5VJLJ MY8:.Z]K?3H>09OWZN$I;T:JO$:BK,QMM;\,WA[^5#1>GW=QR#,YU7\-QL=>) M[Z'%'C^ K&]0!\4Z<]V.K?B44H>9]:WX>'\]KI47&YNRR[..>[GQBN8I@!C& MFCGO.2',]?5;;LQ7D ,VZ&M"ZQC19>_(7?9,I:RVL?&=)=OVUL9W6QOJ:66] MP[OWZ=83^ND)_#]O.[T9A6BR7FZ7]N2V>26W:]^V>:+]CU#9557VZMZ!6LE1 M7NWEZR7#2W0);+S4.TB7P)648I4:JF&;O@V4(GH&-JMG8'M]T*=U"N2)CVO: M!8(N6^H7N/+%_4*,SQY&S-(@BKX+@GNJ_&4*&"06*KF!'X-0+-KT+FYN Q7U M::%T8V9)LA[=VES\7IV:I8T(:]09.=^&?I(#&BR2 +"4,-A[?A)G8Z:62CO$ M53?%\@!BF/J 5(Q3AMG 05F.FA7O)=EX#*H-G 7 -?P,0 +=TT0FN\F% H*E MA"74E?Y@\OP)2CQH$:5 L2'Y'(6=WZZOOY32>7ZG3@+*;/U6Q-I%G$8FKC;U M;T&N QD5Z D-$N^8YQ@A )&^@LH'[Z^XG:(\8T"G6]>ZL;54K\'9E$F,KM) M&$>5IP(>B(][T)RQ?)B)RW:8N:?,,FZ6_.B8/1^%,XX+^YSO1L0?R5=&$9 M&;.; 5&@FLN*&T=T@"%]ES6-Y;?8KWP$.5\4G[J/@4X,9'IL]]'Y7D!Y M:JBNG%,08:+;;(7%5' 3M%@@'V@$((%9,0KQL%-MG""$88QL'!7=WM<%'CCD M"FM\\ZIN,4T2G@XC]+O<(//0UIR0*,5X:FYF[X*I&5I*U%6(1GDF% TZG;'!.C%,V 98'IX?M,F0) M)T+P%J84/656'[WED#$C #^_/) :#"J&D)H/)()A]@$!#Y M!-=9&'-9@AH"U,[4H,_&'JBX>@6.5KM8&(TM8)/;2=2)0[ J$@8<#D3P+P., MHCDI P89INDX8;^R/K_L!_7NJ3RBGN]T6!I?+(/UP.Z,1B[[=\Q^IH^N\2/Z M*VH"<")8<4I#;K31@(Z'40C4!>8U9NJ :<#-TY)QT:=!],A,*0!$T.%&/!HR MNSK=<_Q7AW!UG7 *TQ]HMJKJ7;5O:-3J#VS+T0W7ZRF&03U'8/.8IV08+N+\:(TP,+'(%9 M I9.E.$NGC?C-> ^#")&45($D//04&F[=:K!0+!^N?U,F"\]U7H8P62P4*Z8 MB?H[97^!D!U0!T,IZ[FWC$I$=[UB=DMVT7.;0,+,$3R^>E=HR,XQ1*-Q'KW* M@3]#5>H'\(VRAW/[GM.KK9B6I?4$?HYIYF"BJ>N/69Q[AH(PP\U<+BPN>MWN MVYYB=RQ=5\D%QFN92+AQ0L=SWC)9>V&IYENB&=T.433-(!>W/,S(0XIO!8\] M@ZF*G,74:$KP0DI4S( *,PQ<]RE&M*<&+"I%&K+(+QJMP80G'",=I!NW6W?< MO*I=> 9U9!2RPUKH;*%VS$,(BYK3>7#\@&TCY$%_EP?:F5O6O4KPA<1''RXE M/FI-IFK\!/4GTS+@L7G.9(-Z.30LZY13<=V/LI3<%$"1R&WH/B6VU'?<[_=Q ME(5>)U_"@/UW]5R$,UT*6J<.08L)][E2Z@Y#F,+]I* /P+V;)?E.#3-H69I9 MG ZC,;Z$!ZY]W*5QBRPQ/$S ]L0 @*R[IQ%W#*88&$9X4J+/#EE0 MEK0PR'!C; RJ#_46.RW)-@;8\:AT".N]'Q(?OGP[PDA_&G5N1^, E.>;EVK7 MN")?V/9F-B)W_!@&:-">T5/@1AS=Q\X(MV0?*4;'89Y.ZG2XA8H!8I:2B)O9 MBQ]U4#./^BBS1DA@?1K2 MX 6G\VOTXRB@[*+&KV F+&V%846@CB'CDA?K#H'M@ ,P\\;HK6[E<7(L %>C M+QM/ TD[$#^DD:9WE%BYFR M(M%CR';TZ0\WR!*>G0M8S4]4HP9(,-V)5\XHOL'3B?-J&GD^PAP'/V >7%FP MS$^2RZ1.,J:N/P U,9L ;?D:2H M4FG-3 @[1%^[7R*(I9T-'UFMR)9M7,^9NO@ MJ:\^S]A/"C(C#K.:6?HLIS^>4,OE"$9,X./%B4\4%$B'+/TIS'TW-'K WIF= M-2D,I,#)0G=($RD_.AR7LL4*9<%NY0E-4EZM8EKO8BYJK8U$JML+G!S MTZ%4MG9XLE4R P'FC8)I6V25@>GK)3SQ;K8?:L9]]4 #P\?*E(O5T_EH6 M>.4+15[>W#4&U_(53(L*Y]X;.9.Y/Q&1Y0N(C;F_(Q3] -"YBS':_//O\52Y M\J5DN#CI%.!*YYY!OS3_&Z0:OX1O32_Q /<]/ZO,G5J,@M)XQ)09AS]+R@4* M"1Q4;XSZ.-*8D$00<+O9QU@+< JJ'<:+0 RS\ 4PR\&88G59 I_M>D3;AH*I M7[/YEK,.V>X6KAK'YF?4II608%VLN-OJ1>&\UJ\JS[Y Z6)3)(0]. M[%/N8\1^\IU_1F1P+7VVCOH),Y58BC7RY)N7IGV5I\NRVD(,FPN'!$*P:K'@ M5@S*_,&/,ZRK!2)DE)^[X^?6DG$4\BT[1HCY WS\QR%E<@DIGQU4@L?A=W"< MIX&X),M+=[&C<(,LUU^Y[&=29Z9\BEWZXD1<23/R#RXM \>:I6XO,<4LP1P? M7*/]BLH0TO2 "U> 7-FR!4Y9=E":KC2%4O[0E&/F4($1#3?V^S/.9$+_*SQ- M/H((BS!0CUH@H6Y:2%JF_;,^N"&@Z@.6'#4-#K"4ZY+XQ2]^*#*K;Z8%84#@ ME,X!2-MD0IY:[:TQ;F*:9S&SJ3WX]#')SXZQC5O4" #&@VXB)YACCM0F#9- M_\Y8%96'J=]5*JZ2,*GN.NC9S;Z AW/9NF!4S+,#+TP"JO/1:>1Z@ ;Y*4N> M 9 /J3A><*6 %;K'3W#"ZL0KF+!W[&";TL?KD" M20E&ZN329]MS'?;253YZ#DQS.7K)OL=OYPNT;;EGZKC&O)59_N%\^3);_D*] M=W[/,&5+,=?>5F1UKWNJ;)K6GF^NGRRLLK?^[KYS5613UXX @:ZB'QP"7=GJ M&4> @-W=]\UCT,#F46W[\)2E*K*B=8\ V)YV>'1ILM:S#PX"2[;-8["!JE43 M+ZL[,=K[MF(<^9X7T!>KY'8N65%GSN66 %S-TC76L:*XN$K&'S?4O;I-!%AB M'__X^OOMG41N/]_(Y/KS>W+W[U_O;M_?7G^]_7"WH-5V['LK<% )!V!L8I,1 MYDZ7 MS@?/PQ]7,/@H@%B\QD#VS!384F9@+W>^/^@OF^409C> E&0?!L_\KR M1YCJ\/885& O48%F'(P*6OIHQ3:_:X=7>VOZ$6WN.*3)S#-;(MYGZ@E5C:2_ M#6-*R>_PW# A']AN2%'9B.BJ-"7A)V"GU>![I,%#5?@]E0[MRG"LW!6K*I"G M OT40,:*7&L)<0DH[5FT>@CN:S%\!%$\6:0L==K;LPFHNM16<>>.?#64[A=9 MZ&2>#Y;^4M_$@T-P!Z193X;UQG[#U6UVE?/,O,VNKF&D&N%PFSU^X'[1#1ZG MHGPY'HEM< N/3E"K6Z2O; I9#T='/-JD1T_.6W:]&"OON; K+4XU)-7L\CK)BV;4:E0>L('T'DPJZ*GF]&1*6K?7''H2I-<: MTC.[4D\SFT-Z@IYJ3D\]25=K) C@"D(6F:>0A0FGO!IR&ZPU ET] VZHX=J:+UNJ5^P<1OY4.G MNZJ5G^]2-BM2L9FG+TS956@LX$T!GMVI>J'Y0M35+,XQ/HDJ;:#KJ&J"G; MEGJ64D5-5:*6 ^HHL1MV /3>1+PH_9XJK!T&JZJ :W00B[6E +(EHRN %=[0-3(:D=FWA'34W\O8;JS@PCJ.!OVU/N(V&9U=2S2HJ13A&2T%U MR39ZPB\Z+I U7=+4*M%@X1>M<2Q-R>JIK?*+B@&*=1K+)]9JGI(E'FW2HR>W MF.KGCN='4,/[:8DFD: JK_#^2A/*NHXN%%-L MIP0')UT[2*RXH>LWA 3?(9U -ZIL=+=;@JN&U+4WAV6$!#_MO@ -P<<-F !W MO)$?YBU5'\YT\]F0-.7 5GJKX-.3-'U]I0BQ][R+>=N3>L9!]&FK]YX!3+:] MV0L0>\\+E23,O-QP??0,3\V-=@VH5F/]ZA6::D_MJB[9I]BI;CU<;4G7Z[V/ MW7846+9DV%6J 8KE,_:_,/UFS0#UWL8E=T/!3)<>+1%G!;S7;G M;K'4+TW2G-LJ^W0--%#4S:>:GSF$WQJP:K4%Z[E@P-3KBH%&@]6N50U4H;C6 M**[<-FRSYKHP>_8ZQUIP][XQ0LFRC1I"]6P0H$F**LCZ\%$XP[9J M7==!8' ML+*#\CH%@#]&,?P9$C>+8QJZ$^PJ.'3">TK2&(9U7-P;*V(7%T&4)&_)VAWI M1I.:+EE;*G8()MZ3B7N661,6/DOP:Y)F:C5$0+.AJDNJU:T)5-NHF 1_HPF']*I;K"S<@>%FGBZ[TG4U\;UVL9C@^OSUI' M#H:DJ=O2 IM!#H+K-QT.L=HNVT]N"-4O48\="^G30133P@Y*G1];\_3:FP'= M%4=#:HXCU91L;9MYTA0DB:,A%Z:R:<.S8?AL*Y(T2=?6;J@T $ *E#02K4:M ZS: E07;M(3L,0W;KZ$$)6FH<+6F2H=:% ME)[-:]1A+5Z4]0.Z3RU,,= S#M3HR8N!A)=9R G,UJMG_XJY/X+F_IY =92KU_B)A.VZQ813;5FABQ@I(:34D@JNKB#@FB M.Q>BLV2[CL5)!"4UCI(46:]+//KD=FC]W+T_V1_4(PZLSKFG )?1* JYYY>0 M*$N3% Q5?VO3Z+K[(.+1DS]Z @N8QJP3KM7C[Z7#G.PEE_,%84R>\7I)Q'*XJ57.'Q^^;F/,)V3 MTJ6?PWB&D'O:Z4^=YQ!BF-+YW@T9DD"^H*X+\P]QT_N^F)U;@VY\G>I5A( M%C ,?7W^_O9/([><;F5Q_?D_N_OWKW>W[V^NOMQ_N5MB[ K"5 M !N%+(/:0=WYJQ,XH4O)W9#2=%5ZL(!I%9A>^"&8(%$&8WB)A(5M*2:J8R"$ M.6G3#7$"8'=6'?,[1K:0?12W8,NH%3WU"L/O4F$-=+"VBAY.9)6OII+WU*6C M/I""KDI$4[2#.+5G!*_Y_L0G#PG5+R)[G22KI?A&@MFY??7QX5<;P TG\*X3>JS7+-PZ TK*9^2'1F@?FKQK&I!WCC)D)E'+OY"_\[\ M!R< -(IC:OLNNGZ12*,G65;WF2/7@D":0R#P4S)-ZTF!ZO5RM0@ZAE%(-U-* MDY\4RF6%+>RZ40:ZA,3@18!BZ0=4(B%-V[E/:DO=KB[V!ZN!2NG:1Q(W9\EI M7Z.)$Z039LD%/KAK"4RLQ';MY#A5-P2_5>IRVWO:+K3@MH4"<@_@(D6QO[56 M;$/I1>U)MKHWR9P7;ZFFI"E[RR'!7LL0_1+3L>-[16_X';RWS-"[=>2^D?G35M27-JN+@ M/*U;PU,8N 505C5+ZO6JN-QB=^?I.CD:PYJXAXG;!.,1<'B+HSD]236%=UDQ M? S2;N]4;\%I"XU0@<^<%,,W 7422MB4.M&@D\$?.VK41I&1)2E=<;ZBXOD* M4S_6=LWY,1SS+$7:0I-"!%]IDL:^B^FSF+C03H%H6 ?)3FR_.#3W!Y38NQ9 M$&)VLVH,(IA-2N-1J\W/$\94&P4G^UBR]HP#II7XJD(XZR@9X[7/M9O?DEA1 M/'0O>-60\PQ)J52!8'^ '#KLO&,(5I#MSEAJ!.6JABGIAGH:TCWNL;[GJTO] MI&^>7O?63O5^\IV^'_BIGV<8L%(5PR@ T/Z4L#V.="+B0?6/WQ4'CX(9/@7: MFN%?3A/$Q\ZD0IJJ.%/2')5O2*KUW-GP1^:F17@+@CGL]I]I[GU(30C7E<(U MSN@LC;*=8;NN9(M=XZJG;LQN -:\AABZD:U2W0AE*0*MFZV).L"*K>$TL_ MB@TY 833B]W:[IFX.[O]%7*@FQ96E91*1XZ?IPU[^^ +QF4E)[9IW=%K%L%; M3#.HSM+F2J UI+>&IBN\ME4]VFOL^6BC4?#F94]3M:LZH4&8/0(( @CU,8!K MIBL_3;6D1_NI1 *:).Q7XB=)Q@H)NU'2UB0]39',9]]6:"ZL='/OI$;!=X>/ M]6TZ.]\LS\B4%.5T;-@>.%J2T:V2%E5/%JUM;.B,8T*Z+?4:5WJ@62 V#*G; M.PZ(3\_2M>/HFV@T\E.L-L#3]%QX Z9&0W>?;;9G;JEXN D(REBBC+M9PF;R MDTC8;(PI_26F QK'-$^YE<@K1<9/JF3LQ.3!"3+ZYJ79NVH^+GD0U.*)"U7Q M>I) 8& M_6KG!U[#3+#[LQ,0K!O<\4/B.F,_=8)_M',7S-(-R3*>NZ-/8X&E2::Z]V:% MX+=5!TNR41:PYK4>'?CN8F_W=NG*"[.G2KIFO&VTGFPX"G1%ZIEJ35 @9,)& MF9"7ZH]&XY@.L17- R5^"']3>,5' \?Z^K67 M-I7WZAN"OPM54E5MG2#:)3.A]5*J9O$BGAJ0[+YIU,;:^:8AJ95:L(DT@:=U MU:SBZ# ?H3Q7>PN4G%%%LS;4XA.D+4B[EL7ZWJ58#*K MRC+=X'C6X8G&W@8>#<'SCVOOKRQ!/W<0Q01<7:)VX+>.9I*8 AX3RO4.2<;! M8F"LM)1\3$/+JUI$"8MA7\84G&CPF*\>?2\=YB@IOYA#6YF]XO0!L%FZ_ J' MSR\_]Q&F _MF/O G\,TQ'P2__"U!+ 0(4 Q0 ( "2!85:P$>G4"1D M %VB 1 " 0 !C9FUS+3(P,C,P,S Q+FAT;5!+ 0(4 M Q0 ( "2!85;ZE#Y%9P( '$' 1 " 3@9 !C9FUS M+3(P,C,P,S Q+GAS9%!+ 0(4 Q0 ( "2!859-:)*W\0D %M9 5 M " &UL4$L! A0#% @ )(%A5NN8R